Cargando…
High Dose ESAs Are Associated with High iPTH Levels in Hemodialysis Patients with End-Stage Kidney Disease: A Retrospective Analysis
OBJECTIVE: Anemia and secondary hyperparathyroidism are the two most common complications associated with chronic kidney disease. Erythropoiesis-stimulating agents (ESAs) are widely used in the management of anemia in hemodialysis patients. A reverse correlation has been established between hyperpar...
Autores principales: | Chen, Lan, Ling, Yi-Sheng, Lin, Chun-Hua, He, Jin-Xuan, Guan, Tian-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649021/ https://www.ncbi.nlm.nih.gov/pubmed/26636058 http://dx.doi.org/10.3389/fpubh.2015.00258 |
Ejemplares similares
-
Hypocalcemia after thyroidectomy: iPTH levels and iPTH decline are predictive? Retrospective cohort study()
por: Cannizzaro, Matteo Angelo, et al.
Publicado: (2018) -
A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients
por: Villa-Bellosta, Ricardo, et al.
Publicado: (2017) -
Low serum iPTH at the end of surgery is the earliest predictor of postoperative hypocalcemia after total thyroidectomy
por: Lalos, Alexandros, et al.
Publicado: (2023) -
The Current Role of Parathyroid Fine-Needle Biopsy (P-FNAB) with iPTH-Washout Concentration (iPTH-WC) in Primary Hyperparathyroidism: A Single Center Experience and Literature Review
por: Obołończyk, Łukasz, et al.
Publicado: (2022) -
iPTH is not a significant factor influencing the tacrolimus C/D ratio
por: Westphal, Florian, et al.
Publicado: (2022)